Form 483 · FEI 3042366712

Form 483 issued March 13, 2026 · Phoenix, Arizona

Inspection
Mar 9 – Mar 13, 2026
Investigators
Andra Lepnis· Lan T. Tran
Observations
2
Pages
5
FEI number
3042366712

In short: On March 13, 2026, FDA issued a Form 483 with 2 observations to an FDA-inspected site in Phoenix, Arizona (FEI 3042366712) after an inspection that ran Mar 9 – Mar 13, 2026. The investigators were Andra Lepnis and Lan T. Tran. Most observations concern clinical (BIMO); the most-cited regulation is 21 CFR 312.62 (investigator recordkeeping and record retention).

At a glance

2 of 2 observations on this 483 concern clinical (bimo).

Clinical (BIMO)2

Most cited: 21 CFR 312.62(b) (1×) · 312.60 (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Failure to prepare or maintain adequate and accurate case histories with respect to observations and data…

  2. 02

    An investigation was not conducted in accordance with the signed statement of investigator and investigational plan…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at an FDA-inspected site?

FDA listed 2 observations on this Form 483, mostly about clinical (BIMO). The most-cited regulation is 21 CFR 312.62 (investigator recordkeeping and record retention). The opening words of each observation are shown on this page.

Who inspected an FDA-inspected site?

Andra Lepnis and Lan T. Tran are named on this Form 483, for the inspection of Mar 9 – Mar 13, 2026. Each investigator has a profile showing what they cite most.

When was an FDA-inspected site inspected by FDA?

The inspection ran Mar 9 – Mar 13, 2026, and the Form 483 is dated March 13, 2026.

How do I get the full Form 483 for an FDA-inspected site?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free